6949 — Pell Bio Med Technology Co Balance Sheet
0.000.00%
Last trade - 00:00
- TWD8.62bn
- TWD7.70bn
- TWD18.03m
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 116 | 708 | 1,106 |
Net Total Accounts Receivable | |||
Net Total Receivables | 10.6 | 6.41 | 7.93 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 132 | 725 | 1,127 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 250 | 299 | 261 |
Net Intangible Assets | |||
Long Term Investments | |||
Other Long Term Assets | |||
Total Assets | 394 | 1,044 | 1,418 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 44.2 | 57.2 | 89.3 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Minority Interest | |||
Total Liabilities | 169 | 243 | 248 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Treasury Stock | |||
Total Equity | 225 | 801 | 1,170 |
Total Liabilities & Shareholders' Equity | 394 | 1,044 | 1,418 |
Total Common Shares Outstanding |